- Home
- BHFAO vs SNN Comparison
BHFAO vs SNN Comparison
Compare BHFAO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHFAO | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 1400 | N/A |
| Industry | Life Insurance | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 13.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | BHFAO | SNN |
|---|---|---|
| Price | $16.75 | $32.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | N/A | ★ 778.5K |
| Earning Date | N/A | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.24% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $58.59 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | N/A | $23.91 |
| 52 Week High | N/A | $38.79 |
Technical Indicators
Market Signals| Indicator | BHFAO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 67.78 | 41.58 |
| Support Level | $16.35 | $31.89 |
| Resistance Level | $16.86 | $34.13 |
| Average True Range (ATR) | 0.32 | 0.62 |
| MACD | 0.13 | -0.08 |
| Stochastic Oscillator | 92.94 | 11.21 |
Price Performance
Historical ComparisonAbout BHFAO Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.